Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literature.

Although integrating novel technologies into nonclinical drug development can counteract declining R&D success, their path to regulatory acceptance is often unclear and uncertain as they are not subject to a single, predictable regulatory approval fr…

Preview only. Read the full abstract at the source